Literature DB >> 12527925

Expression of proteinase-activated receptor-2 in human pancreatic cancer: a possible relation to cancer invasion and induction of fibrosis.

Osamu Ikeda1, Hiroshi Egami, Takatoshi Ishiko, Shinji Ishikawa, Hidenobu Kamohara, Hideki Hidaka, Seiji Mita, Michio Ogawa.   

Abstract

The proteinase-activated receptor-2 (PAR-2) is a G protein-coupled receptor that is cleaved and activated by trypsin. To clarify the presence of PAR-2 in human pancreatic cancer, the expression of PAR-2 was analyzed by RT-PCR, immunoblotting and immunocytochemistry using 5 human pancreatic cancer cell lines. And to evaluate the biological significance, immunohistochemical expression of PAR-2 in malignant and non-malignant human pancreatic tissues was examined using paraffin-embedded sections. The presence of PAR-2 was confirmed in all 5 pancreatic cancer cell lines and all 21 paraffin-embedded specimens from human pancreatic cancer examined. The expression of PAR-2 was found to be higher in the tissues with infiltrative growth pattern than those with expansive growth pattern. Moreover, significantly higher expression of PAR-2 was observed in the tissues which were accompanied by severe fibrosis. Even in the same specimen, the intensity of immunoreactivity tended to be stronger in the part with severe fibrosis than that with mild fibrosis. Similarly, the higher expression of PAR-2 was observed in chronic pancreatitis with severe fibrosis than with mild fibrosis. Taken together, these results suggest that the activation of PAR-2 is involved in cancer invasion and the induction of fibrosis in human pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527925

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  15 in total

1.  Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.

Authors:  Keren Borensztajn; Paul Bresser; Chris van der Loos; Ilze Bot; Bernt van den Blink; Michael A den Bakker; Joost Daalhuisen; Angelique P Groot; Maikel P Peppelenbosch; Jan H von der Thüsen; C Arnold Spek
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

2.  Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.

Authors:  Roberta Caruso; Francesco Pallone; Daniele Fina; Valentina Gioia; Ilaria Peluso; Flavio Caprioli; Carmine Stolfi; Alessandra Perfetti; Luigi Giusto Spagnoli; Giampiero Palmieri; Thomas T Macdonald; Giovanni Monteleone
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Selected hemostatic parameters in patients with pancreatic tumors.

Authors:  Anna Deskur; Daria Sałata; Marta Budkowska; Barbara Dołęgowska; Teresa Starzyńska; Wojciech Błogowski
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

4.  PAR-2 promotes invasion and migration of esophageal cancer cells by activating MEK/ERK and PI3K/Akt signaling pathway.

Authors:  Jiexia Sheng; Xu Deng; Qiliang Zhang; Hua Liu; Nannan Wang; Ziquan Liu; Erqing Dai; Quanjun Deng
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

Review 5.  Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer.

Authors:  Andrea Pia Elste; Iver Petersen
Journal:  J Mol Histol       Date:  2010-06-20       Impact factor: 2.611

6.  Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis.

Authors:  Shu-Qiang Yue; Yan-Ling Yang; Ke-Feng Dou; Kai-Zong Li
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

7.  MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation.

Authors:  Yiming Ma; Wuyun Bao-Han; Xue Lv; Yuntao Su; Xinhua Zhao; Yongmei Yin; Xingmao Zhang; Zhixiang Zhou; Wallace K MacNaughton; Hongying Wang
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

Review 8.  Activation of blood coagulation in cancer: implications for tumour progression.

Authors:  Luize G Lima; Robson Q Monteiro
Journal:  Biosci Rep       Date:  2013-09-04       Impact factor: 3.840

9.  Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.

Authors:  Franziska Zeeh; David Witte; Thomas Gädeken; Bernhard H Rauch; Evelin Grage-Griebenow; Nadja Leinung; Sofie Joline Fromm; Stephanie Stölting; Koichiro Mihara; Roland Kaufmann; Utz Settmacher; Hendrik Lehnert; Morley D Hollenberg; Hendrik Ungefroren
Journal:  Oncotarget       Date:  2016-07-05

10.  Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.

Authors:  Jingjia Ye; Makiko Kawaguchi; Yukihiro Haruyama; Ai Kanemaru; Tsuyoshi Fukushima; Koji Yamamoto; Chen-Yong Lin; Hiroaki Kataoka
Journal:  Cancer Sci       Date:  2013-11-25       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.